Capstone Investment Advisors, LLC Incyte Corp Call Options Transaction History

Capstone Investment Advisors, LLC

$29.5 Billion
Q2 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 12, 2024	SELL	$52.16 - $64.19 $62,591 - $77,028	-1,200 Reduced 60.0%	800 $50,000
Q3 2023 Nov 13, 2023	SELL	$57.77 - $65.93 $17,331 - $19,779	-300 Reduced 13.04%	2,000 $115,000
Q1 2023 May 09, 2023	SELL	$70.23 - $86.01 $42,138 - $51,606	-600 Reduced 20.69%	2,300 $166,000
Q4 2022 Feb 10, 2023	BUY	$67.18 - $84.11 $33,590 - $42,055	500 Added 20.83%	2,900 $232,000
Q3 2022 Nov 10, 2022	BUY	$66.18 - $82.86 $66,180 - $82,860	1,000 Added 71.43%	2,400 $160,000
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $641,946 - $806,846	-9,700 Reduced 87.39%	1,400 $106,000
Q1 2022 May 13, 2022	SELL	$66.02 - $79.71 $369,712 - $446,375	-5,600 Reduced 33.53%	11,100 $882,000
Q4 2021 Feb 11, 2022	BUY	$63.34 - $74.11 $19,002 - $22,233	300 Added 1.83%	16,700 $1.23 Million
Q3 2021 Nov 15, 2021	BUY	$68.67 - $84.02 $288,414 - $352,884	4,200 Added 34.43%	16,400 $0
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $183,701 - $201,319	-2,300 Reduced 15.86%	12,200 $0
Q1 2021 May 17, 2021	SELL	$76.02 - $100.5 $585,354 - $773,850	-7,700 Reduced 34.68%	14,500 $1.18 Million
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $395,626 - $478,730	4,900 Added 28.32%	22,200 $1.93 Million
Q3 2020 Nov 16, 2020	SELL	$85.07 - $109.69 $110,590 - $142,597	-1,300 Reduced 6.99%	17,300 $1.55 Million
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $756,636 - $1.11 Million	10,200 Added 121.43%	18,600 $1.93 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $1.04 Million - $1.42 Million	-16,500 Reduced 66.27%	8,400 $615,000
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $343,288 - $449,884	4,700 Added 23.27%	24,900 $2.17 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $553,432 - $657,552	7,600 Added 60.32%	20,200 $1.5 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $249,968 - $301,580	3,400 Added 36.96%	12,600 $1.07 Million
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $400,428 - $555,471	6,300 Added 217.24%	9,200 $791,000
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $35,100 - $41,964	600 Added 26.09%	2,900 $184,000
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $142,025 - $170,729	2,300 New	2,300 $159,000

Others Institutions Holding INCY

# of Institutions

628

Shares Held

198M

Call Options Held

766K

Put Options Held

476K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $15B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account